Doctor Florian Kahles
RWTH University Hospital Aachen, Aachen (Germany)
GLP-2 predicts cardiovascular outcomes in patients with myocardial infarction and increases atherosclerosis in mice
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Bench to bedside in acute coronary syndromes: from infarction size in animal studies to long-term development of chronic coronary syndrome
GLP-2 as an indicator and modulator of acute inflammation improves cardiac function and survival in sepsis
Event: ESC Congress 2022
Topic: Leukocytes, Inflammation, Immunity
Session: Acquired forms of heart failure: cancer and inflammatory disorders
The gut hormone GIP predicts CV prognosis in patients with acute myocardial infarction
Event: ESC Congress 2021 - The Digital Experience
Topic: Epidemiology, Prognosis, Outcome
Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters
The gut hormone GLP-2 predicts cardiovascular risk in patients with acute myocardial infarction
Event: ESC Congress 2020
Topic: Epidemiology, Prognosis, Outcome
Session: Acute Coronary Syndromes ePosters
Activation of the GIP system attenuates pathological vascular remodeling by decreasing infiltration and proinflammatory activation of monocytes in ApoE-/- mice
Event: ESC Congress 2017
Topic: Inflammation, growth factors and signal transduction-vascular
Session: Vascular inflammation
The PDE-4 inhibitor roflumilast reduces body weight and improves glucose metabolism by increasing energy expenditure and mitochondrial respiration
Event: ESC Congress 2016
Topic: Metabolism and metabolic syndromes
Session: Integrative physiology and pathology
ESC 365 is supported by
